NCT00195455View on ClinicalTrials.gov

Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.

PHASE4CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

March 31, 2007

Conditions
Postmenopause
Interventions
DRUG

Trimegestone

DRUG

17b Estradiol

Trial Locations (6)

44340

Guadalajara

64000

Monterrey

64460

Monterrey

01030

Mexico City

01090

Mexico City

02990

Mexico City

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195455 - Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women. | Biotech Hunter | Biotech Hunter